Despite Crisis In Some Areas, Analysts Do Not Expect Delta To Derail Recovery
Executive Summary
Numbers of COVID-19 patients in the hospital are rising in many states and a few hospitals have been stretched to their limit, but data compiled by Credit Suisse suggests that the surgical capacity of US hospitals will stabilize in September.
You may also be interested in...
Hospital Staffing Shortages Could Impede Recovery Of Procedure Volumes
Even as COVID-19 hospitalization rates are declining, expected staff shortages could force more hospitals to postpone surgeries and interventions in the coming months.
J&J Finishes Tough Year With Optimism For 2021
J&J expects its medical device sales to begin growing rapidly by the middle of 2021 as the pandemic subsides.
News We’re Watching: FDA Approves Medtronic's Affera, Roche's CGM Moves Closer To Approval, And More
Medtech Insight's News We're Watching covers medtech industry and research news you may have missed. This week, the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Florence, Italy, included new results from studies of Roche's continuous glucose monitor and Medtronic's 780G insulin pump, Medtronic moved closer to earning FDA approval for its Affera ablation mapping and ablation system, and Linus Health expanded its technology for finding signs of cognitive problems in speech data.